Reichard; Gregory A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Reichard; Gregory A..The latest application filed is for "nk1 antagonists".
- Reichard; Gregory A. - Ann Arbor MI
- Reichard; Gregory A. - Lovettsville VA
- Reichard; Gregory A. - Morris Plains NJ
| Patent | Date |
|---|---|
| Nk1 Antagonists App 20170283434 - Paliwal; Sunil ; et al. | 2017-10-05 |
| Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis Grant 9,700,562 - Sciotti , et al. July 11, 2 | 2017-07-11 |
| NK.sub.1 antagonists Grant 9,688,693 - Paliwal , et al. June 27, 2 | 2017-06-27 |
| Triazine Compounds and Compositions Thereof and Methods for Treating Malaria and Chemoprophylaxis App 20160213675 - Sciotti; Richard J. ; et al. | 2016-07-28 |
| Substituted triazines for malaria treatment and chemoprophylaxis Grant 9,334,246 - Sciotti , et al. May 10, 2 | 2016-05-10 |
| Substituted Triazines for Malaria Treatment and Chemoprophylaxis App 20150210652 - Sciotti; Richard J. ; et al. | 2015-07-30 |
| Nk1 Antagonists App 20140336158 - Paliwal; Sunil ; et al. | 2014-11-13 |
| NK1 antagonists Grant 8,796,299 - Paliwal , et al. August 5, 2 | 2014-08-05 |
| Nk1 Antagonists App 20130023503 - Paliwal; Sunil ; et al. | 2013-01-24 |
| NK.sub.1 antagonists Grant 8,273,895 - Paliwal , et al. September 25, 2 | 2012-09-25 |
| Nk1 Antagonists App 20110098468 - Paliwal; Sunil ; et al. | 2011-04-28 |
| NK.sub.1 antagonists Grant 7,902,366 - Paliwal , et al. March 8, 2 | 2011-03-08 |
| Substituted morpholine compounds for the treatment of central nervous system disorders Grant 7,659,394 - Barta , et al. February 9, 2 | 2010-02-09 |
| Fused ring NK.sub.1 antagonists Grant 7,498,438 - Xiao , et al. March 3, 2 | 2009-03-03 |
| NK1 antagonists Grant 7,122,677 - Reichard , et al. October 17, 2 | 2006-10-17 |
| NK1 antagonists App 20060199815 - Paliwal; Sunil ; et al. | 2006-09-07 |
| NK.sub.1 antagonists Grant 7,049,320 - Paliwal , et al. May 23, 2 | 2006-05-23 |
| Fused ring NK1 antagonists App 20060040975 - Xiao; Dong ; et al. | 2006-02-23 |
| Substituted morpholine compounds for the treatment of central nervous system disorders App 20050245519 - Barta, Nancy S. ; et al. | 2005-11-03 |
| NK1 antagonists Grant 6,878,732 - Wrobleski , et al. April 12, 2 | 2005-04-12 |
| NK1 antagonists App 20040072854 - Wrobleski, Michelle Laci ; et al. | 2004-04-15 |
| NK1 antagonists App 20040072867 - Shih, Neng-Yang ; et al. | 2004-04-15 |
| Selective neurokinin antagonists Grant 6,635,630 - Shih , et al. October 21, 2 | 2003-10-21 |
| NK 1 antagonists App 20030158173 - Paliwal, Sunil ; et al. | 2003-08-21 |
| NK1 antagonists App 20030144270 - Reichard, Gregory A. ; et al. | 2003-07-31 |
| Use of neurokinin receptor antagonists to treat androgen-dependent diseases App 20030092602 - Leach, Michael W. ; et al. | 2003-05-15 |
| Selective neurokinin antagonists App 20030064980 - Shih, Neng-Yang ; et al. | 2003-04-03 |
| Selective Neurokinin Antagonists App 20020123491 - Shih, Neng-Yang ; et al. | 2002-09-05 |
| Selective neurokinin antagonists Grant 6,436,928 - Shih , et al. August 20, 2 | 2002-08-20 |
| Substituted oximes and hydrazones as neurokinin antagonists App 20020111348 - Reichard, Gregory A. ; et al. | 2002-08-15 |
| Substituted oximes and hydrazones as neurokinin antagonists App 20010011089 - Reichard, Gregory A. ; et al. | 2001-08-02 |
| Substituted oximes, hydrazones and olefins as neurokinin antagonists Grant 5,945,428 - Shih , et al. August 31, 1 | 1999-08-31 |
| Substituted oximes, hydrazones and olefins as neurokinin antagonists Grant 5,840,725 - Reichard , et al. November 24, 1 | 1998-11-24 |
| Substituted oximes, hydrazones and olefins as neurokinin antagonists Grant 5,696,267 - Reichard , et al. December 9, 1 | 1997-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 